Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-20

Clinical Trial Update: Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing semaglutide to placebo to evaluate effects on intestinal barrier function in adults with Type 2 Diabetes Mellitus; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes, Chronic Inflammation | Phase 4 | Status: COMPLETED